Published in Medical Letter on the CDC and FDA, March 28th, 2010
CarriGen is indicated as a bone void filler of the pelvis, extremities and spine, including posterolateral spine fusion.
Cleared to be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA